By inhibiting FASN, the enzyme in lipid metabolism responsible for synthesizing palmitate from acetyl-CoA and malonyl-CoA using NADPH [34], combined with standard treatments might significantly weaken cancer cells (Table 1). Here, FASN is linked to cancer.